Release test results
99.576%HPLC purity · meets ≥ 99.5% spec
Mass-spec identityConfirmed · 20.12 mg
Related impurities (total)0.424%
Endotoxin<1.0 EU/mg
HPLC retention time5.23 min
MethodHPLC + LC-MS
ResultPass · meets spec
Lot record
CompoundGLP-3-RT
Presentation20 MG
Lot numberRGX-26-RGX-698
COA numberNS-2026-05080
Test date07 Sep 2026
Release date10 Sep 2026
Independent labNordicstar Labs
StatusSuperseded
GLP-3-RT — lot history
| Lot | Presentation | Tested | HPLC purity | Status |
|---|---|---|---|---|
| RGX-26-RGX-1001 | 15 MG | Sep 8, 2026 | 99.770% | Current |
| RGX-26-RGX-1004 | 40 MG | Sep 8, 2026 | 99.594% | Current |
| RGX-26-RGX-696 | 40 MG | Sep 8, 2026 | 99.728% | Superseded |
| RGX-26-RGX-1000 | 10 MG | Sep 7, 2026 | 99.663% | Current |
| RGX-26-RGX-699 | 15 MG | Sep 7, 2026 | 99.714% | Superseded |
| RGX-26-RGX-698 this lot | 20 MG | Sep 7, 2026 | 99.576% | Superseded |
| RGX-26-RGX-1003 | 30 MG | Sep 6, 2026 | 99.556% | Current |
| RGX-26-RGX-800 | 10 MG | Sep 6, 2026 | 99.607% | Superseded |
| RGX-26-RGX-794 | 60 MG | Sep 6, 2026 | 99.690% | Superseded |
| RGX-26-RGX-798 | 20 MG | Sep 5, 2026 | 99.676% | Superseded |
| RGX-26-RGX-796 | 40 MG | Sep 5, 2026 | 99.759% | Superseded |
| RGX-26-RGX-1006 | 60 MG | Sep 4, 2026 | 99.739% | Current |
| RGX-26-RGX-700 | 10 MG | Sep 4, 2026 | 99.569% | Superseded |
| RGX-26-RGX-695 | 50 MG | Sep 4, 2026 | 99.652% | Superseded |
| RGX-26-RGX-1002 | 20 MG | Sep 3, 2026 | 99.587% | Current |
| RGX-26-RGX-697 | 30 MG | Sep 3, 2026 | 99.721% | Superseded |
| RGX-26-RGX-795 | 50 MG | Sep 3, 2026 | 99.766% | Superseded |
| RGX-26-RGX-1005 | 50 MG | Sep 2, 2026 | 99.701% | Current |
| RGX-26-RGX-799 | 15 MG | Sep 2, 2026 | 99.752% | Superseded |
| RGX-26-RGX-797 | 30 MG | Sep 2, 2026 | 99.614% | Superseded |
| RGX-26-RGX-694 | 60 MG | Sep 2, 2026 | 99.659% | Superseded |
!
Research use only
This lot record documents a research compound sold for laboratory use only — not for human or animal consumption. Results are as tested by Nordicstar Labs; retained samples are archived for five years. Research Use Agreement →